Introduction {#s1}
============

The pyridine nucleotide NAD^+^ (nicotinamide adenine dinucleotide) not only serves as a ubiquitous coenzymatic redox carrier in metabolic reactions, but also participates in intracellular signal transduction ([@bib11]; [@bib63]). NAD^+^ is the precursor of the second messenger cyclic ADP-ribose (cADPR), which triggers calcium (Ca^2+^) release from intracellular stores in various organisms ([@bib33]; [@bib52]; [@bib43]; [@bib89]). NAD^+^ also functions as the ADP-ribose donor and the acetyl group acceptor in protein ADP-ribosylation and deacetylation reactions, respectively ([@bib47]; [@bib17]; [@bib28]; [@bib46]; [@bib43]). In response to environmental stimuli, cellular NAD^+^ can also be released into the extracellular space by active exocytosis or diffusion through transmembrane transporters in living cells or passive leakage across membrane in collapsed tissues ([@bib16]; [@bib25]; [@bib71]; [@bib2]). It has recently been shown that extracellular NAD^+^ (eNAD^+^) plays an important signaling role in numerous physiological and pathological processes ([@bib12]; [@bib39]; [@bib4]).

In animal cells, eNAD^+^ can be processed by ectoenzymes such as CD38, CD157, and mono(ADP-ribosyl)transferases (ARTs) ([@bib12]). CD38 is a multifunctional enzyme attached to the extracellular surface of the plasma membrane, which utilizes NAD^+^ as the substrate to produce cADPR ([@bib19]; [@bib26]; [@bib51]; [@bib56]; [@bib57]; [@bib64]). ARTs are glycosylphoshpatidylinositol-anchored or secreted ectoenzymes that use NAD^+^ to ADP-ribosylate lipid raft-associated signaling proteins ([@bib62]; [@bib40]; [@bib71]; [@bib7]; [@bib91]). eNAD^+^ may also be perceived by cell-surface receptors. [@bib58] reported that NAD^+^ promotes intracellular \[Ca^2+^\] elevation in the human purinoceptor P2Y~11~-tranfected astrocytoma cells, but not in untransfected cells. They also showed that, in human granulocytes, treatment with the selective and potent P2Y~11~ inhibitor NF157 and down-regulation of P2Y~11~ expression by short interference RNA, both prevented NAD^+^-induced intracellular \[Ca^2+^\] increases and chemotaxis ([@bib58]). These results demonstrate that P2Y~11~ is involved in eNAD^+^-triggered transmembrane signaling. Several other studies using similar approaches have also indicated that purinoceptors, including P2Y~1~, P2X~1~, P2X~4~, and P2X~7~, are engaged in eNAD^+^-mediated signaling ([@bib60]; [@bib38]; [@bib49]). However, NAD^+^per se has never been demonstrated to bind to purinoceptors, and thus the identity of eNAD^+^ receptors still remains a mystery in animals.

In plants, NAD^+^ and its derivatives have also been shown to function in stress tolerance and/or defense signaling ([@bib30]; [@bib1]; [@bib66]). Overexpression of the bacterial NAD^+^ biosynthesis gene *nadC*, which increases intracellular NAD^+^ levels, enhances defense gene expression and bacterial pathogen resistance ([@bib65]). In contrast, mutations in *FLAGELLIN-INSENSITIVE4*, a de novo NAD^+^ biosynthesis gene, suppress stomatal immunity ([@bib55]). Furthermore, overexpression of *Arabidopsis thaliana Nudix hydrolase homolog 6* (*AtNUDT6*), which encodes an ADP-ribose/NADH pyrophosphohydrolase, and knockout of *AtNUDT6*, *AtNUDT7*, or *AtNUDT8* lead to alterations of intracellular NADH levels and salicylic acid (SA)-mediated defense signaling ([@bib9]; [@bib34]; [@bib45]; [@bib31]).

We have recently shown that exogenous NAD^+^ induces SA-dependent and -independent *PATHOGENESIS-RELATED* (*PR*) gene expression and disease resistance ([@bib83]). Importantly, we found that pathogen-induced hypersensitive response causes leakage of NAD^+^ into the extracellular fluid at concentrations sufficient to induce *PR* gene expression and disease resistance ([@bib83]). These results provided the first line of evidence that NAD^+^ may also play a signaling role in plant extracellular space. However, since proteins with significant homology to animal CD38/CD157, ARTs, and purinoceptors are absent in plants, it remains unclear if eNAD^+^ is an endogenous signaling molecule in plants and if plants use similar mechanisms to process or perceive eNAD^+^ ([@bib43]; [@bib75]; [@bib91]; [@bib82]). We have shown that expression of the human NAD^+^-metabolizing ectoenzyme CD38 partially compromises systemic acquired resistance (SAR) in *Arabidopsis* ([@bib84]), which strongly suggests that plants may use different mechanisms to sense eNAD^+^.

In order to understand eNAD^+^ and its signaling role in plants, we performed a forward genetic screen in *Arabidopsis* to identify mutants insensitive to exogenous NAD^+^ (*ien*) treatment ([@bib85]). Characterization of several *ien* mutants revealed that the Mediator complex subunits MED14/STRUWWELPETER and MED16/SENSITIVE TO FREEZING6 /IEN1 as well as the Elongator complex function downstream of eNAD^+^ ([@bib85], [@bib86]; [@bib5]). However, no receptor genes were identified in the forward genetic screen. In this study, we employed a reverse genetic approach to identify eNAD^+^ receptors in *Arabidopsis*. We demonstrate that the lectin receptor kinase (LecRK), LecRK-I.8, is a potential eNAD^+^ receptor and plays a positive role in plant basal immunity. Our findings indicate that cell-surface lectin receptors can potentially act as eNAD^+^-sensing receptors and present direct evidence for eNAD^+^ being a novel endogenous signaling molecule in plants.

Results {#s2}
=======

Exogenous NAD^+^ induces profound transcriptome changes toward immune response {#s2-1}
------------------------------------------------------------------------------

Thus far, we have only shown that exogenous application of NAD*^+^* induces *PR* gene expression in the model plant *Arabidopsis* ([@bib83]). To identify genes induced by NAD^+^ at the genome level, we performed a microarray experiment to monitor NAD^+^-induced transcriptome changes in wild-type Col-0 plants (National Center for Biotechnology Information Gene Expression Omnibus series number GSE76568). Triplicate experiments were performed independently, and the data were analyzed to identify genes that showed a twofold or higher induction or suppression with a low *q* value (≤0.05). Compared to the mock (water) treatment, NAD^+^ addition caused profound transcriptional changes, including upregulation of 2155 genes and downregulation of 2014 genes. In the upregulated genes, those involved in plant immune responses were significantly enriched, whereas in the downregulated genes, those associated with responses to hormone stimuli, such as auxin stimulus, were overrepresented ([Figure 1A](#fig1){ref-type="fig"}). The NAD^+^-upregulated genes include a large number of pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI) and SA pathway genes ([Supplementary file 1A](#SD6-data){ref-type="supplementary-material"}). In contrast, expression of several jasmonic acid (JA)/ethylene (ET)-mediated defense pathway genes, including the widely used defense marker gene *PLANT DEFENSIN1.2*, was suppressed by NAD^+^ treatment ([Supplementary file 1A](#SD6-data){ref-type="supplementary-material"}). Interestingly, more than 88% of the NAD^+^-induced genes were also activated by the bacterial pathogen *Pseudomonas syringae* pv. *tomato* (*Pst*) DC3000 carrying the effector avrRpt2 ([Figure 1B](#fig1){ref-type="fig"}) ([@bib78]). These results are in agreement with the strong resistance induced by NAD^+^ against the hemibiotrophic bacterial pathogen *P. syringae* ([@bib83]).10.7554/eLife.25474.003Figure 1.Exogenous NAD^+^-induced transcriptome changes.(**A**) Gene Ontology (GO) term enrichment test of the genes that were upregulated and downregulated by NAD^+^ treatment at 4 hr showed that genes involved in plant defense such as innate immune response, immune response, and response to chitin were significantly enriched in the upregulated genes, whereas those associated with responses to hormone stimuli, such as auxin stimulus, were overrepresented in the downregulated genes. (**B**) Overlap between the genes that were upregulated by NAD^+^ treatment at 4 hr and that by *Pst* DC3000/*avrRpt2* at least at one time point of 4, 8, and 12 hr post-inoculation ([@bib78]).**DOI:** [http://dx.doi.org/10.7554/eLife.25474.003](10.7554/eLife.25474.003)

Mutations in the *LecRK-I.8* gene inhibit NAD^+^-induced *PR* gene expression and disease resistance {#s2-2}
----------------------------------------------------------------------------------------------------

Further analysis of the microarray data revealed that a group of receptor kinase (RK) including several cell wall-associated kinase (WAK) genes were induced by the NAD^+^ application ([Supplementary file 1B](#SD6-data){ref-type="supplementary-material"}). We isolated transferred DNA (T-DNA) insertion lines for fourteen of the RK genes ([Supplementary file 1B](#SD6-data){ref-type="supplementary-material"}), tested their responsiveness to NAD^+^, and found that NAD^+^-induced resistance to the bacterial pathogen *P. syringae* pv. *maculicola* (*Psm*) ES4326 was reduced in one T-DNA insertion line (Arabidopsis Biological Resource Center accession code Salk_066416) ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). Salk_066416 carries a T-DNA insertion in the gene At5g60280, which was predicted to encode the legume-like (L-type) lectin receptor kinase-I.8 (LecRK-I.8) ([@bib13]). We then isolated two more T-DNA insertion lines (Salk_005125 and Salk_206382) for further investigation. The three T-DNA insertion lines had reduced transcript levels ([Figure 2---figure supplement 1B and C](#fig2s1){ref-type="fig"}). Salk_066416 has previously been named *lecrk-I.8--2* ([@bib79]). Salk_005125 and Salk_206382 were thus named *lecrk-I.8--3*, and *lecrk-I.8--4*, respectively ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}). The *lecrk-I.8--4* mutant accumulated higher transcript levels than *lecrk-I.8--2* and *lecrk-I.8--3*, and was considered a weak allele ([Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}). NAD^+^-induced expression of *PR1* and resistance to *Psm* ES4326 were significantly inhibited in all three *lecrk-I.8* alleles but not in the extracellular ATP (eATP) receptor mutant *dorn1-3* ([@bib22]), and induction of *PR2* and *PR5* was also repressed in *lecrk-I.8--2* and *lecrk-I.8--3* ([Figure 2A--D](#fig2){ref-type="fig"}). These results indicate that LecRK-I.8 is a component of the eNAD^+^-induced defense signaling pathway. Interestingly, induction of *PR2* and *PR5* was significantly enhanced in the *dorn1-3* mutant ([Figure 2B and C](#fig2){ref-type="fig"}), which is consistent with eATP being a negative regulator of SA signaling ([@bib21]).10.7554/eLife.25474.004Figure 2.LecRK-I.8 functions in extracellular NAD^+^-triggered defense signaling pathway.(**A**) to (**C**) NAD^+^-induced expression of *PR1* (**A**), *PR2* (**B**), and *PR5* (**C**) was reduced in the *lecrk-I.8* mutants. Plants were treated with 0.2 mM NAD^+^ solution or water. Leaf tissues were collected 20 hr later for qPCR analysis. Expression levels were normalized against *UBQ5*. Data represent the mean of three independent samples with standard deviation (SD). Asterisks indicate significant differences between the wild type (WT) and the mutants (\*p\<0.05, \*\*p\<0.01, two-way ANOVA). (**D**) NAD^+^-induced resistance to the bacterial pathogen *Psm* ES4326 was decreased in the *lecrk-I.8* mutants. Plants were treated as in (**A**). Five h later, the plants were inoculated with a *Psm* ES4326 suspension (OD~600~ = 0.001). The bacterial titers were determined 3 d post-inoculation. Data represent the mean of eight independent samples with SD. Asterisks indicate significant differences between the wild type and the mutants (\*p\<0.05, \*\*p\<0.01, two-way ANOVA). Cfu: colony-forming units. (**E**) Expression levels of *LecRK-I.8* were elevated in two *35S:LecRK-I.8* transgenic lines. Data represent the mean of three independent samples with SD. Different letters above the bars indicate significant differences (p\<0.05, one-way ANOVA). (**F**) and (**G**) Induction of *PR1* (**F**) and *PR5* (**G**) by NAD^+^ was enhanced in the *35S:LecRK-I.8* lines. The experiments were performed as in (**A**) except that the plants were treated with 0.1 mM NAD^+^. All experiments were repeated three times with similar trends.**DOI:** [http://dx.doi.org/10.7554/eLife.25474.004](10.7554/eLife.25474.004)10.7554/eLife.25474.005Figure 2---source data 1.LecRK-I.8 functions in extracellular NAD^+^-triggered defense signaling pathway.**DOI:** [http://dx.doi.org/10.7554/eLife.25474.005](10.7554/eLife.25474.005)10.7554/eLife.25474.006Figure 2---figure supplement 1.Exogenous NAD^+^-induced *Psm* ES4326 resistance in T-DNA insertion lines of 14 candidate genes and transcript levels of *LecRK-I.8* in three T-DNA insertion lines.(**A**) Leaves of 4-week-old soil-grown plants were infiltrated with 0.2 mM NAD^+^ or water. Five h later, the infiltrated leaves were inoculated with a *Psm* ES4326 suspension (OD~600~ = 0.001). Eight leaves per genotype per treatment were collected 3 d post-inoculation and pooled to examine the growth of the pathogen. WT: wild type. Cfu: colony-forming units. (**B**) The T-DNA insertion sites in Salk_066416 (*lecrk-I.8--2*), Salk_206382 (*lecrk-I.8--3*), and Salk_005125 (*lecrk-I.8--4*) and the positions of the three pairs of primers used for real-time qPCR analysis of *LecRK-I.8* transcript levels. (**C**) Transcript levels of *LecRK-I.8* in *lecrk-I.8--2*, *lecrk-I.8--3*, and *lecrk-I.8--4* were significantly lower than those in the wild type (WT). Leaves of 4-week-old soil-grown plants were infiltrated with (+) or without (-) 0.2 mM NAD^+^ solution. Total RNA was extracted 4 hr later and subjected to real-time qPCR analysis. Expression levels were normalized against *UBQ5*. Data represent the mean of three independent samples with SD. Different letters above the bars indicate significant differences (p\<0.05, one-way ANOVA of square-root transformed data). The comparison was made separately for each treatment. The experiment was repeated with similar trends.**DOI:** [http://dx.doi.org/10.7554/eLife.25474.006](10.7554/eLife.25474.006)10.7554/eLife.25474.007Figure 2---figure supplement 2.Characterization of *35S:LecRK-I.8* transgenic lines.(**A**) Expression levels of *LecRK-I.8* in *35S:LecRK-I.8-GFP* transgenic lines. Total RNA was extracted from the wild type (WT) and 11 single T-DNA insertion homozygous *35S:LecRK-I.8* transgenic lines and subjected to qPCR analysis. Expression levels were normalized against *UBQ5*. Data represent the mean of three independent samples with SD. (**B**) Basal resistance of seven *35S:LecRK-I.8* transgenic lines expressing different levels of *LecRK-I.8*. Plants were inoculated with a *Psm* ES4326 suspension (OD~600~ = 0.001). The bacterial titers were determined 3 d post-inoculation. Data represent the mean of eight independent samples with SD. The experiments were repeated with similar trends.**DOI:** [http://dx.doi.org/10.7554/eLife.25474.007](10.7554/eLife.25474.007)

To test if overexpression of *LecRK-I.8* could enhance *Arabidopsis* responsiveness to NAD^+^, we transformed a *35S:LecRK-I.8* construct into wild-type Col-0 plants. Intriguingly, we were unable to identify transgenic lines expressing very high levels of *LecRK-I.8*. The expression levels of *LecRK-I.8* in all of the obtained 11 transgenic lines increased less than fourfold ([Figure 2---figure supplement 2A](#fig2s2){ref-type="fig"}), suggesting that overexpression of *LecRK-I.8* may be detrimental to plant growth and development. Nevertheless, although the transgenic lines, which expressed higher levels of *LecRK-I.8* than the wild type, did not show enhanced disease resistance ([Figure 2---figure supplement 2B](#fig2s2){ref-type="fig"}), NAD^+^-induced expression of *PR1* and *PR5* in these lines was significantly enhanced ([Figure 2E--2G](#fig2){ref-type="fig"}). This result supports that LecRK-I.8 functions in eNAD^+^-mediated defense pathway.

LecRK-I.8 is located in the plasma membrane {#s2-3}
-------------------------------------------

Both DORN1 and LecRK-I.8 contain a putative transmembrane domain and two putative arginine-glycine-aspartic acid (RGD)-binding motifs that likely mediate plant cell wall-plasma membrane interactions ([@bib36]) ([Figure 3A](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}), suggesting their possible plasma membrane localization. Indeed, DORN1 has been shown to be localized in the plasma membrane ([@bib14]). To determine the subcellular localization of LecRK-I.8, we transformed a *35S:LecRK-I.8-GFP* (*Green Fluorescence Protein*) construct into the *lecrk-I.8--2* mutant. Very low levels of LecRK-I.8-GFP protein were detected in three out of eleven single insertion homozygous transgenic lines ([Figure 3---figure supplement 2A](#fig3s2){ref-type="fig"}), which is consistent with the hypothesis that overexpression of *LecRK-I.8* may be harmful to plants. Nevertheless, the low level of LecRK-I.8-GFP complemented the enhanced disease susceptibility phenotype of *lecrk-I.8--2* (see below) ([Figure 3---figure supplement 2B](#fig3s2){ref-type="fig"}), indicating that LecRK-I.8-GFP is biologically active. Unfortunately, we were unable to detect any GFP fluorescence in the transgenic *Arabidopsis* plants accumulating LecRK-I.8-GFP. To circumvent this problem, we transiently expressed LecRK-I.8-GFP in *Nicotiana benthamiana*. The LecRK-I.8-GFP fusion protein in *N. benthamiana* appeared to be localized in the plasma membrane ([Figure 3B](#fig3){ref-type="fig"}). To confirm this subcellular localization, we co-expressed LecRK-I.8-GFP and AHA2-mCherry in *N. benthamiana*. As shown in [Figure 3C](#fig3){ref-type="fig"}, the GFP and mCherry signals in the co-transformed *N. benthamiana* epidermal cell precisely overlapped with each other. Since *AHA2* encodes a well-established plasma membrane localized P-type H^+^- ATPase ([@bib27]), this result indicates that LecRK-I.8 is localized at the plasma membrane.10.7554/eLife.25474.008Figure 3.Subcellular localization of the LecRK-I.8-GFP fusion protein.(**A**) Putative RGD-binding motifs in DORN1 and LecRK-I.8. (**B**) Confocal images of *N. benthamiana* epidermal cells transiently expressing GFP (Left) and LecRK-I.8-GFP (right). (**C**) Confocal images of *N. benthamiana* epidermal cells transiently co-expressing LecRK-I.8-GFP and AHA2-mCherry. Left: LecRK-I.8-GFP, middle: AHA2-mCherry, and right: merged image.**DOI:** [http://dx.doi.org/10.7554/eLife.25474.008](10.7554/eLife.25474.008)10.7554/eLife.25474.009Figure 3---figure supplement 1.Alignment between the NAD receptor LecRK-I.8 and the ATP receptor DORN1.The amino acid sequences of LecRK-I.8 and DORN1 were aligned using the CLUSTALW tool at the PBIL (Pôle Bioinformatique Lyonnais). LecRK-I.8 and DORN1 (LecRK-I.9) have approximately 81.5% amino acid sequence similarity. The transmembrane domain and the kinase domain (KD) were underlined in blue and red, respectively.**DOI:** [http://dx.doi.org/10.7554/eLife.25474.009](10.7554/eLife.25474.009)10.7554/eLife.25474.010Figure 3---figure supplement 2.Characterization of *35S:LecRK-I.8-GFP lecrk-I.8--2* transgenic lines.(**A**) LecRK-I.8-GFP protein levels in *35S:LecRK-I.8-GFP lecrk-I.8--2* transgenic lines. Total protein was extracted from the wild type (WT) and 11 single T-DNA insertion homozygous *35S:LecRK-I.8-GFP lecrkI.8--2* transgenic lines and subjected to SDS-PAGE and analyzed by immunoblot analysis using a monoclonal anti-GFP antibody. The Thermo Scientific SuperSignal West Femto Maximum Sensitivity Substrate and prolonged exposure (1 hr) of the x-ray film were employed to detect the LecRK-I.8-GFP band. *The asterisk indicates an unspecific band, indicating equal loading.*. (**B**) Basal resistance of the three *35S:LecRK-I.8-GFP lecrk-I.8--2* transgenic lines showing LecRK-I.8-GFP protein. Plants were inoculated with a *Psm* ES4326 suspension (OD~600~ = 0.0001). The bacterial titers were determined 3 d post-inoculation. Data represent the mean of eight independent samples with SD. Different letters above the bars indicate significant differences (p\<0.05, one-way ANOVA). The experiment was repeated with similar trends.**DOI:** [http://dx.doi.org/10.7554/eLife.25474.010](10.7554/eLife.25474.010)

The kinase domain of LecRK-I.8 possesses kinase activity {#s2-4}
--------------------------------------------------------

LecRK-I.8 contains a cytoplasmic kinase domain (KD) ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). To test if LecRK-I.8 is an active kinase, we expressed the LecRK-I.8KD fragment as a Maltose-Binding Protein (MBP)-LecRK-I.8KD fusion protein in *Escherichia coli*. The MBP-LecRK-I.8KD recombinant protein was purified using amylose resin and subjected to kinase activity assay ([Figure 4](#fig4){ref-type="fig"}). Simultaneously purified MBP protein was included in the experiment as a negative control ([Figure 4](#fig4){ref-type="fig"}). As shown in the autoradiograph, the LecRK-I.8KD protein exhibited a strong autophosphorylation activity and also phosphorylated myelin basic protein, a substrate commonly used for in vitro kinase assays. This result indicates that LecRK-I.8 possesses kinase activity.10.7554/eLife.25474.011Figure 4.Kinase activity of the LecRK-I.8 kinase domain.An autoradiograph (right panel) showing that the kinase domain (KD) of LecRK-I.8 is active based on autophosphorylation and phosphorylation of the myelin basic protein. The purified MBP and MBP-LecRK-I.8KD proteins used for kinase activity assays were separated in a different SDS-PAGE gel (left panel), and the white arrow in the left panel indicates the expected size of the MBP-LecRK-I.8KD protein band. The experiment was repeated with similar results.**DOI:** [http://dx.doi.org/10.7554/eLife.25474.011](10.7554/eLife.25474.011)

LecRK-I.8 specifically binds NAD^+^ {#s2-5}
-----------------------------------

Plasma membrane localization of LecRK-I.8 plus its active cytoplasmic kinase domain suggest a putative role for LecRK-I.8 as a receptor for an extracellular ligand. To test whether NAD^+^ is a ligand binding to LecRK-I.8, we generated transgenic *Arabidopsis* plants expressing the extracellular lectin domain (amino acids (AAs) 23 to 283) of LecRK-I.8 fused to GFP (eLecRK-I.8-GFP). The eLecRK-I.8-GFP protein was immunoprecipitated using an anti-GFP antibody ([Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}) and subjected to binding assays with ^32^P-labeled NAD^+^. A significant NAD^+^ binding activity was detected for the immunoprecipitated eLecRK-I.8-GFP protein, but not for the GFP protein immunoprecipitated from transgenic plants expressing GFP using the same antibody ([Figure 5A](#fig5){ref-type="fig"}), indicating that the NAD^+^ binding activity is likely specific to eLecRK-I.8. A specific NAD^+^ binding activity was also detected for an eLecRK-I.8-HA-His fusion protein transiently expressed in *N. benthamiana* ([Figure 5B](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1B](#fig5s1){ref-type="fig"}). Furthermore, NAD^+^ binding activity was detected for the recombinant fusion protein MBP-eLecRK-I.8 but not for MBP, MBP-eDORN1 (AAs 22 to 288), and MBP-eLecRK-I.3 (AAs 22 to 286) ([Figure 5C](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1C](#fig5s1){ref-type="fig"}). The extracellular domain of LecRK-I.6 (AAs 22 to 286), which is the closest homolog of LecRK-I.8 ([@bib13]), did not bind NAD^+^, either ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}), suggesting that LecRK-I.6 may not be an eNAD^+^ receptor. Since LecRK-I.8, DORN1, LecRK-I.3, and LecRK-I.6, all are L-type LecRKs and belong to the LecRK-I clade ([@bib13]), this result indicates that not all of the extracellular lectin domains of L-type LecRKs can bind NAD^+^. In addition, we detected a dramatic increase of NAD^+^ binding activity in the membrane fractions of the *35S:LecRK-I.8* transgenic plants and a clear decrease of NAD^+^ binding activity in the membrane fractions of the *lecrk-I.8--2* mutant plants ([Figure 5D](#fig5){ref-type="fig"}). These results are consistent with the increased and decreased NAD^+^ responsiveness in the *35S:LecRK-I.8* and *lecrk-I.8--2* plants, respectively ([Figure 2](#fig2){ref-type="fig"}). Interestingly, there were differences in ligand affinities between the membrane fractions of the *35S:LecRK-I.8* plants and the wild type, which might suggest possible conformation changes when LecRK-I.8 is overexpressed in plants. Finally, the immunoprecipitated eLecRK-I.8-GFP protein showed a typical saturation curve for NAD^+^ binding with a dissociation constant (*K*~d~) of 436.5 ± 104.8 nM ([Figure 5E](#fig5){ref-type="fig"}), which falls well below the extracellular NAD(H) concentration (\~0.4 mM) in pathogen-infected leaf tissues ([@bib83]), and thus indicates a relatively high affinity. On the other hand, we found that 5 μM of NAD^+^ was able to significantly induce the early PAMP responsive genes *GLUTATHIONE S-TRANSFERASE1* (*GST1*) and *FLG22-INDUCED RECEPTOR-LIKE KINASE1* (*FRK1*) ([Figure 5---figure supplement 3](#fig5s3){ref-type="fig"}), indicating that the NAD^+^ concentrations required to trigger defense responses are significantly higher than the *K*~d~ value of LecRK-I.8, which is rather unusual and difficult to reconcile with a primary ligand sensor function of LecRK-I.8.10.7554/eLife.25474.012Figure 5.LecRK-I.8 binds NAD^+^.(**A**) to (**C**), Binding of ^32^P-labeled NAD^+^ to immunoprecipitated GFP and eLecRK-I.8-GFP proteins (**A**), purified eLecRK-I.8-HA-His protein (**B**), and recombinant MBP, MBP-eLecRK-I.8, MBP-eDORN1, and MBP-eLecRK-I.3 proteins (**C**). (-) in (**B**) is an empty vector control. Approximately 0.5 g *Arabidopsis* leaf tissues, 1 g *N. benthamiana* leaf tissues, and \~5 μg recombinant proteins were used for each binding assay in (**A**), (**B**), and (**C**), respectively. (**D**) Binding of ^32^P-labeled NAD^+^ to the microsomal fractions of *35S:LecRK-I.8*, wild-type (WT), and *lecrk-I.8--2* plants. Specific binding was determined by subtracting the binding in the presence of 1000-fold unlabeled NAD^+^ from the total binding in the absence of cold competitor. (**E**) Saturation binding assay for LecRK-I.8. Immunoprecipitated eLecRK-I.8-GFP proteins were incubated with the indicated concentrations of ^32^P-labeled NAD^+^ for 30 min. Free NAD^+^ was removed by washing. Data were plotted as a specific binding with SD of three experiments. The dissociation constant (*K*d) was calculated by one site specific binding saturation model using GraphPad Prism 5 ([www.graphpad.com](http://www.graphpad.com)). (**F**) Competitive binding assay for LecRK-I.8. Samples containing 250 nM of ^32^P-labeled NAD^+^ in the presence of 100 nM to 1 mM of unlabeled nucleotides were assayed for specific binding of ^32^P-labeled NAD^+^. Inhibition constant (*K*~i~) values were calculated in GraphPad Prism 5 using the one site Fit *K*~i~ competition model. In (**A**), (**B**), (**C**), and (**E**), results from three independent experiments were combined (error bars represent SD).**DOI:** [http://dx.doi.org/10.7554/eLife.25474.012](10.7554/eLife.25474.012)10.7554/eLife.25474.013Figure 5---source data 1.LecRK-I.8 binds NAD^+^.**DOI:** [http://dx.doi.org/10.7554/eLife.25474.013](10.7554/eLife.25474.013)10.7554/eLife.25474.014Figure 5---figure supplement 1.Purified eLecRK-I.8 proteins.(**A**) Proteins immunoprecipitated from the wild-type (WT), *35S:GFP* and *35S:eLecRK-I.8-GFP* plants using the anti-GFP antibody. (**B**) Proteins purified from *N. benthamiana* leaves infiltrated with Agrobacteria carrying the pCAMBIA1300S-eLecRK-I.8-HA-His plasmid or the empty pCAMBIA1300S vector (-) using the *HisPur Cobalt resin. The asterisk indicates an unspecific band.*. (**C**) Proteins purified from *E. coli* cells expressing the recombinant MBP, MBP-eLecRKI.8, MBP-eDORN1, and MBP-eLecRK-I.3 fusion proteins using the amylose resin.**DOI:** [http://dx.doi.org/10.7554/eLife.25474.014](10.7554/eLife.25474.014)10.7554/eLife.25474.015Figure 5---figure supplement 2.NAD^+^ binding assay of the recombinant MBP-eLecRK-I.6 protein.(**A**) Proteins purified from *E. coli* cells expressing the recombinant MBP, MBP-eLecRKI.8, and MBP-eLecRK-I.6 fusion proteins using the amylose resin. (**B**) Binding of ^32^P-labeled NAD^+^ to recombinant MBP, MBP-eLecRK-I.8, and MBP-eLecRK-I.6 proteins. Approximately 5 μg recombinant proteins were used for the binding assay. Results from three independent experiments were combined (error bars represent SD).**DOI:** [http://dx.doi.org/10.7554/eLife.25474.015](10.7554/eLife.25474.015)10.7554/eLife.25474.016Figure 5---figure supplement 3.Induction of several early PAMP-responsive genes by low concentrations of NAD^+^.Four-week-old soil-grown wild-type Col-0 plants were treated with the indicated concentration of NAD^+^ solution. Leaf tissues were collected 30 min later for qPCR analysis. Expression levels were normalized against *UBQ5*. Data represent the mean of three independent samples with SD. The experiment was repeated with similar trends.**DOI:** [http://dx.doi.org/10.7554/eLife.25474.016](10.7554/eLife.25474.016)

However, binding of NAD^+^ to LecRK-I.8 suggests that LecRK-I.8 may be a receptor for eNAD^+^. To test the specificity of the binding between NAD^+^ and LecRK-I.8, we analyzed the ability of various unlabeled nucleotides to compete for binding of ^32^P-labeled NAD^+^. While unlabeled NAD^+^ exhibited strong competition for binding with ^32^P-labeled NAD^+^, other nucleotides including NADP^+^, ATP, ADP, and AMP showed little or no competition ([Figure 5F](#fig5){ref-type="fig"}). Given the structural similarity between NAD^+^ and NADP^+^ and the fact that NADP^+^ can similarly induce immune responses in plants ([@bib83]), it is surprising that NADP^+^ did not efficiently compete for binding with ^32^P-labeled NAD^+^ ([Figure 5F](#fig5){ref-type="fig"}). These results suggest that LecRK-I.8 may be a receptor specific for NAD^+^.

Mutations in *LecRK-I.8* particularly inhibit NAD^+^-induced defense responses {#s2-6}
------------------------------------------------------------------------------

If LecRK-I.8 is a receptor specific for NAD^+^, mutations in *LecRK-I.8* should only affect NAD^+^-induced defense signaling. To test this hypothesis, we treated the *lecrk-I.8* mutants and wild type with NAD^+^ and three other defense inducers, NADP^+^, flg22 (a peptide corresponding to the 22 AAs of the conserved N-terminal part of flagellin), and SA. As shown in [Figure 6A and B](#fig6){ref-type="fig"}, while NAD^+^ triggered significantly lower levels of *PR1* gene expression and *Psm* ES4326 resistance in the *lecrk-I.8* mutants than those in the wild type, NADP^+^, flg22, and SA induced similar levels of *PR1* gene expression and *Psm* ES4326 resistance in the *lecrk-I.8* mutants and the wild type. These results indicate a specific role for LecRK-I.8 in eNAD^+^-triggered signaling. Moreover, LecRK-I.8 has previously been shown to mediate *Pieris brassicae* egg extract-triggered *PR1* gene expression ([@bib37]), but the identity of the elicitor(s) in the egg extracts is unclear. To test if one of the elicitors in insect egg extracts is NAD^+^, we treated the previously generated *35S:CD38* transgenic plants ([@bib84]), *lecrk-I.8--2*, and wild type with *Trichoplusia ni* (cabbage looper) egg extracts following the published protocol ([@bib37]), and analyzed the egg extract-induced *PR1* expression. CD38 is a human NAD(P)-metabolizing ectoenzyme and has been shown to partially block exogenous NAD^+^-induced *PR1* expression and *Psm* ES4326 resistance ([@bib84]). Similarly to *P. brassicae* egg extracts ([@bib37]), *T. ni* egg extracts induced *PR1* gene expression in the wild-type plants, and the induction was dramatically reduced in the *lecrk-I.8--2* mutant ([Figure 6C](#fig6){ref-type="fig"}). Importantly, *T. ni* egg extract-induced *PR1* expression was also significantly inhibited in the *35S:CD38* plants ([Figure 6C](#fig6){ref-type="fig"}). Therefore, insect egg extracts may either contain NAD^+^ as part of their defense inducing activity or induce release of cellular NAD^+^ into the extracellular space. Taken together, our results strongly suggest that LecRK-I.8 is a potential receptor for NAD^+^.10.7554/eLife.25474.017Figure 6.Extracellular NADP^+^-, flg22-, and SA-induced immune responses are not affected in the *lecrk-I.8* mutants.(**A**) NAD^+^-, NADP^+^-, flg22-, and SA-induced *PR1* expression in the wild type (WT) and the *lecrk-I.8* mutants. Plants were infiltrated with 0.2 mM NAD^+^, 0.2 mM NADP^+^, 1 μM flg22, or water. For SA treatment, plants were treated with soil drenches plus foliar sprays of 0.5 mM SA solution or water. Leaf tissues were collected 20 hr later for qPCR analysis. Expression levels were normalized against *UBQ5*. Data represent the mean of three independent samples with SD. Asterisks indicate significant differences between the wild type (WT) and the mutants (\*\*p\<0.01, two-way ANOVA). (**B**) NAD^+^-, NADP^+^-, flg22-, and SA-induced *Psm* ES4326 resistance in the wild type and the *lecrk-I.8* mutants. Plants were treated as in (**A**). Five h after NAD^+^ or NADP^+^ treatment and 24 hr after flg22 or SA treatment, the plants were inoculated with a *Psm* ES4326 suspension (OD~600~ = 0.001). The bacterial titers were determined 3 d post-inoculation. Data represent the mean of eight independent samples with SD. Asterisks indicate significant differences between the wild type and the mutants (\*p\<0.05, \*\*p\<0.01, two-way ANOVA). (**C**) Insect egg extract-induced *PR1* gene expression in *35S:CD38* transgenic plants. Two μL of *T. ni* egg extracts were dropped onto leaves of the WT, *lecrk-I.8--2*, and *35S:CD38* transgenic plants. The treated leaves without petiole were collected 3 d later for qPCR analysis. Leaf tissues from untreated plants were used as the control. Data represent the mean of three independent samples with SD. Different letters above the bars indicate significant differences (p\<0.05, one-way ANOVA). The comparison was made separately for each treatment. All experiments were repeated three times with similar trends.**DOI:** [http://dx.doi.org/10.7554/eLife.25474.017](10.7554/eLife.25474.017)10.7554/eLife.25474.018Figure 6---source data 1.Extracellular NADP^+^-, flg22-, and SA-induced immune responses are not affected in the *lecrk-I.8* mutants.**DOI:** [http://dx.doi.org/10.7554/eLife.25474.018](10.7554/eLife.25474.018)

LecRK-I.8 is not the sole mechanism perceiving eNAD^+^ in *Arabidopsis* {#s2-7}
-----------------------------------------------------------------------

Our results so far have shown that mutations in *LecRK-I.8* partially compromised a low concentration of NAD^+^-induced *PR* gene expression and *Psm* ES4326 resistance. Since *PR* genes are late defense genes, we compared NAD^+^-induced expression of several early defense genes, including *AZELAIC ACID INDUCED1* (*AZI1*), *PHYTOALEXIN DEFICIENT4* (*PAD4*), *NON-INDUCIBLE IMMUNITY1 (NIM1)-INTERACTING1* (*NIMIN1*), *NIMIN2*, *WRKY18*, and *WRKY54*, in wild type and the *lecrk-I.8--2* mutant. As shown in [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}, induction of these early defense genes by NAD^+^ was not significantly affected by the *lecrk-I.8--2* mutation. This result indicates that NAD^+^ perception mechanisms other than LecRK-I.8 still exist in the *lecrk-I.8--2* mutant. To substantiate this conclusion, we treated wild type and the *lecrk-I.8--2* mutant with different concentrations of NAD^+^ and tested NAD^+^-induced defense responses. The expression of *PR* genes and resistance to *Psm* ES4326 activated by 0.2 and 0.4 mM NAD^+^ were significantly reduced in the *lecrk-I.8--2* plants compared with those in the wild type, whereas 0.6 mM NAD^+^ induced similar levels of *PR* gene expression and *Psm* ES4326 resistance in the mutant and the wild type ([Figure 7](#fig7){ref-type="fig"}). These results are consistent with the remaining NAD^+^ binding activity in the membrane fractions of the *lecrk-I.8--2* mutant, supporting the existence of other NAD^+^ receptors and/or perception mechanisms in *Arabidopsis*.10.7554/eLife.25474.019Figure 7.Immune responses induced by different concentrations of NAD^+^ in *lecrk-I.8--2*.(**A**) Comparison of different concentrations of NAD^+^-induced expression of *PR1*, *PR2*, and *PR5* in *lecrk-I.8--2* and the wild type (WT). Leaves of 4-week-old soil-grown plants were infiltrated with the indicated concentrations of NAD^+^. Total RNA was extracted from the infiltrated leaves 20 hr later and subjected to real-time qPCR analysis. Expression was normalized against constitutively expressed *UBQ5*. Data represent the mean of three independent samples with SD. Asterisks indicate significant differences between *lecrk-I.8--2* and the wild type (\*p\<0.05, \*\*p\<0.01, two-way ANOVA). (**B**) Comparison of different concentrations of NAD^+^-induced resistance to *Psm* ES4326 in *lecrk-I.8--2* and the wild type. Leaves of 4-week-old soil-grown plants were infiltrated with the indicated concentrations of NAD^+^. Five h later, the infiltrated leaves were inoculated with a *Psm* ES4326 suspension (OD~600~ = 0.001). The in planta bacterial titers were determined 3 d post-inoculation. Data represent the mean of eight independent samples with SD. Asterisks indicate significant differences between *lecrk-I.8--2* and the wild type (\*\*p\<0.01, two-way ANOVA). Experiments were repeated three times with similar trends.**DOI:** [http://dx.doi.org/10.7554/eLife.25474.019](10.7554/eLife.25474.019)10.7554/eLife.25474.020Figure 7---source data 1.Immune responses induced by different concentrations of NAD^+^ in *lecrk-I.8-2*.**DOI:** [http://dx.doi.org/10.7554/eLife.25474.020](10.7554/eLife.25474.020)10.7554/eLife.25474.021Figure 7---figure supplement 1.NAD^+^-induced expression of several early defense-responsive genes in the *lecrk-I.8--2* mutant.Four-week-old soil-grown wild-type (WT) and *lecrk-I.8--2* plants were treated with 0.2 mM NAD^+^ solution or water. Leaf tissues were collected 4 hr later for qPCR analysis. Expression levels were normalized against *UBQ5*. Data represent the mean of three independent samples with SD. The experiment was repeated with similar trends.**DOI:** [http://dx.doi.org/10.7554/eLife.25474.021](10.7554/eLife.25474.021)

LecRK-I.8 contributes to plant basal immunity {#s2-8}
---------------------------------------------

If eNAD^+^ is an endogenous signaling molecule and LecRK-I.8 is an essential cell-surface receptor for eNAD^+^, mutations in *LecRK-I.8* should compromise immune responses. However, in [Figures 2D](#fig2){ref-type="fig"}, [6B](#fig6){ref-type="fig"} and [7B](#fig7){ref-type="fig"}, where the plants were infected with *Psm* ES4326 at a high dose (an inoculum of OD~600~ = 0.001) ([@bib23]), the bacterial pathogen grew to similar levels in mock (water)-treated wild type and *lecrk-I.8* mutants. The high dose is generally used for disease resistance test and may not be able to resolve differences in disease susceptibility ([@bib35]; [@bib23]). Therefore, we inoculated wild-type and *lecrk-I.8* plants with a low dose (an inoculum of OD~600~ = 0.0001). Under this condition, both *lecrk-I.8--2* and *lecrk-I.8--3* exhibited significantly reduced *PR1* gene induction and significantly enhanced susceptibility to *Psm* ES4326, compared with the wild type and the *dorn1-3* mutant ([Figure 8](#fig8){ref-type="fig"}). We also tested biological induction of SAR in the *lecrk-I.8* mutants and found that SAR induction was not affected in all three *lecrk-I.8* alleles ([Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}). Nevertheless, our results demonstrate that the potential eNAD^+^ receptor LecRK-I.8 plays a positive role in plant immunity.10.7554/eLife.25474.022Figure 8.Basal immunity is compromised in the *lecrk-I.8* mutants.(**A**) *Psm* ES4326-induced *PR1* expression was inhibited in the *lecrk-I.8* mutants. Plants were inoculated with (+) or without (−) a *Psm* ES4326 suspension (OD~600~ = 0.0001). Leaf tissues were collected 24 hr post-inoculation for qPCR analysis. Expression was normalized against constitutively expressed *UBQ5*. Data represent the mean of three independent samples with SD. Different letters above the bars indicate significant differences (p\<0.05, one-way ANOVA). The comparison was made separately for each treatment. WT: wild type. (**B**) and (**C**), The *lecrk-I.8* mutants were more susceptible to *Psm* ES4326 than the wild type. Plants were inoculated with a *Psm* ES4326 suspension (OD~600~ = 0.0001). The bacterial titers in (**B**) were determined immediately and 3 d post-inoculation. Data represent the mean of eight independent samples with SD. Different letters above the bars indicate significant differences (p\<0.05, one-way ANOVA). The comparison was made separately for each time point. Photos showing the disease symptoms in (**C**) were taken 3 d post-inoculation. Experiments in (**A**) and (**B**) were repeated three times with similar trends.**DOI:** [http://dx.doi.org/10.7554/eLife.25474.022](10.7554/eLife.25474.022)10.7554/eLife.25474.023Figure 8---source data 1.Basal immunity is compromised in the *lecrk-I.8* mutants.**DOI:** [http://dx.doi.org/10.7554/eLife.25474.023](10.7554/eLife.25474.023)10.7554/eLife.25474.024Figure 8---figure supplement 1.Biological induction of SAR in *lecrk-I.8* mutants.Three lower leaves on each plant were inoculated with *Psm* ES4326 (OD~600~ = 0.002) (+SAR) or mock-treated with 10 mM MgCl~2~ (-SAR). Two days later, two upper uninfected/untreated leaves were challenge-inoculated with *Psm* ES4326 (OD~600~ = 0.001). The *in plants* bacterial titers were determined 3 d after challenge inoculation. Data represent the mean of eight independent samples with SD. The experiment was repeated with similar trends.**DOI:** [http://dx.doi.org/10.7554/eLife.25474.024](10.7554/eLife.25474.024)

Discussion {#s3}
==========

Here, we present several lines of evidence to demonstrate that LecRK-I.8 is a potential eNAD^+^ receptor in *Arabidopsis*. First, the *LecRK-I.8* gene is induced by exogenous NAD^+^ ([Supplementary file 1B](#SD6-data){ref-type="supplementary-material"}), which is consistent with the observation that receptor-encoding genes are often ligand inducible ([@bib90]). Second, LecRK-I.8 is localized in the plasma membrane and possesses an active cytoplasmic kinase domain ([Figures 3](#fig3){ref-type="fig"} and [4](#fig4){ref-type="fig"}). Third, LecRK-I.8 binds NAD^+^, but not NADP^+^, ATP, ADP, or AMP ([Figure 5F](#fig5){ref-type="fig"}), and three other LecRKs, DORN1, LecRK-I.3, and LecRK-I.6, do not bind NAD^+^ ([Figure 5C](#fig5){ref-type="fig"} and [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). Fourth, mutations in *LecRK-I.8* inhibit NAD^+^-induced, but not NADP^+^-, flg22-, and SA-induced, defense responses ([Figure 6A and B](#fig6){ref-type="fig"}). Finally, mutations in *LecRK-I.8* compromise basal resistance to the bacterial pathogen *Psm* ES4326 ([Figure 8](#fig8){ref-type="fig"}).

NAD^+^ has long been shown to bind to rat brain synaptic membranes ([@bib48]), and recent studies have also indicated that several purinergic P2X and P2Y receptors are involved in eNAD^+^-induced biological responses ([@bib58]; [@bib60]; [@bib38]; [@bib49]). However, there has been no direct evidence demonstrating the binding of NAD^+^ to a known cell-surface receptor. Therefore, the identity of eNAD^+^-binding receptors has remained unclear. Our identification of a LecRK as a potential eNAD^+^ receptor suggests that lectin receptors may directly bind NAD^+^, leading to transmembrane signaling. As lectin receptors are widely distributed in both the animal and plant kingdoms ([@bib29]; [@bib76]), and certain animal and plant lectin domains have convergently evolved similar ligand binding architecture ([@bib54]), animal cells might also use lectin receptors to sense eNAD^+^. This speculation could be tested using receptor-NAD^+^ binding assays.

Identification of a potential eNAD^+^ receptor in *Arabidopsis* provides direct evidence for eNAD^+^ being a bona fide endogenous signaling molecule in plants ([@bib84]). This is consistent with the fact that genes involved in plant immune responses are significantly enriched in the genes upregulated by NAD^+^ and that the majority of the NAD^+^-induced genes are also activated by the bacterial pathogen *Pst* DC3000/*avrRpt2* ([Figure 1](#fig1){ref-type="fig"}) ([@bib78]). These results together should eradicate the skepticism concerning the physiological relevance of eNAD^+^ perception in plants ([@bib32]). Additionally, given the diverse roles played by eNAD^+^ in animal cells ([@bib12]; [@bib44]; [@bib39]; [@bib4]; [@bib61]), further studies with the *Arabidopsis lecrk-I.8* mutants will likely reveal new biological functions for this signaling molecule in plants.

eNAD^+^ may play a role in plant-insect interactions. It has recently been reported that deposition of *P. brassicae* egg batches on *Arabidopsis* leaves induces the SA signaling pathway, which in turn suppresses the JA pathway, thus benefiting the insect progeny ([@bib53]; [@bib15]). By treatment with *P. brassicae* egg extracts, which mimics the effect of oviposition, [@bib37] identified LecRK-I.8 as a potential cell surface receptor for the insect egg-derived elicitors. Although it has been shown that a fraction from purified *P. brassicae* egg lipids is able to induce *PR1* gene expression ([@bib37]), the identity of the elicitors still remains unknown. Three pieces of evidence generated in this study indicate that the defense-inducing activity of the insect egg extract could be, at least, partially attributed to NAD^+^, and/or that the perception of egg extract may lead to release of cellular NAD^+^ into the extracellular space. First, LecRK-I.8 is potentially a cell surface receptor specific for NAD^+^ ([Figure 5](#fig5){ref-type="fig"}). Second, the human NAD(P)-metabolizing ectoenzyme CD38 inhibits *T. ni* egg extract-induced *PR1* gene expression ([Figure 6C](#fig6){ref-type="fig"}). Finally, the majority of *P. brassicae* oviposition-induced receptor-like kinase genes ([@bib53]) are also upregulated by exogenous NAD^+^ addition ([Supplementary file 1C](#SD6-data){ref-type="supplementary-material"}). Thus, insect eggs appear to use NAD^+^ to alter the SA-JA signaling balance in plants for the benefit of the insect progeny.

It has been shown that eNAD^+^ and eATP play multiple, partially overlapping roles in animal immune cells ([@bib39]). One of the best-studied examples is the mechanism activating the P2X~7~ purinoceptor by eNAD^+^ and eATP in T cells and macrophages ([@bib8]; [@bib68]). While ATP activates P2X~7~ through direct binding ([@bib74]; [@bib67]; [@bib20]), NAD^+^ regulates P2X~7~ in these two different cell types via distinct mechanisms. In T cells, NAD^+^ promotes ART-mediated ADP-ribosylation of P2X~7~, which is sufficient for activation of the purinoceptor ([@bib71]; [@bib3]), whereas in macrophages, ADP-ribosylation does not activate P2X~7~ but rather reduces the threshold concentration of ATP needed to turn on the receptor ([@bib41]). Thus, eNAD^+^ and eATP function additively and synergistically in T cells and macrophages, respectively, to regulate P2X~7~ signaling. In contrast, available evidence obtained by studies in *Arabidopsis* indicates that eNAD^+^ and eATP act antagonistically to modulate the SA signaling pathway. eNAD^+^ induces SA accumulation and SA-dependent defense gene expression and disease resistance ([@bib83]), whereas eATP suppresses these defense responses ([@bib21]). In agreement with these results, induction of *PR* genes by exogenous NAD^+^ in the eATP receptor mutant *dorn1-3* is significantly enhanced compared with that in the wild type ([Figure 2A--C](#fig2){ref-type="fig"}). On the other hand, the *dorn1-3* mutation does not significantly affect basal and NAD^+^-induced resistance to the bacterial pathogen *Psm* ES4326 ([Figures 2D](#fig2){ref-type="fig"} and [8B](#fig8){ref-type="fig"}), which may be attributed to the presence of other eATP receptors. Whether knockout of *LecRK-I.8* influences eATP-mediated suppression of SA signaling needs further investigation.

As in animal cells ([@bib88]), eNAD^+^ is likely perceived by multiple receptors and/or mechanisms in plants. Mutations in *LecRK-I.8* only block 0.2 and 0.4 mM NAD*^+^*-induced, but not 0.6 mM NAD^+^-induced, *PR* gene expression and disease resistance ([Figure 7](#fig7){ref-type="fig"}). Furthermore, induction of several early defense responsive genes by 0.2 mM NAD^+^ is not inhibited by the *lecrk-I.8--2* mutation ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). These results indicate that LecRK-I.8 is not the sole eNAD^+^ perception mechanism in *Arabidopsis*. Indeed, the *Arabidopsis* genome contains genes encoding 75 LecRKs (32 G-type, 42 L-type, and 1 C-type) as well as a large number of other RKs and channels ([@bib6]; [@bib76]), many of which are also NAD^+^ inducible and could potentially encode eNAD^+^ receptors. Thus, a genome-wide survey via NAD^+^ binding assays is warranted for identification of other eNAD^+^ receptors in *Arabidopsis*.

It is currently unclear whether eNAD^+^ signaling is specific for *Arabidopsis* or the mustard family (Brassicaceae). Recent genome-wide analyses of LecRKs in multiple plant species revealed that this large family of RKs also exists in other dicots and monocots. For instance, there are 231 LecRKs (180 G-type, 50 L-type, and 1 C-type) in *Populus* ([@bib81]), 173 LecRKs (100 G-type, 72 L-type, and 1 C-type) in rice ([@bib76]), 263 LecRKs (177 G-type, 84 L-type, and 2 C-type) in bread wheat ([@bib72]), and 113 LecRKs (59 G-type, 53 L-type, and 1 C-type) in foxtail millet ([@bib87]). These results strongly suggest that eNAD^+^ receptors may be broadly distributed in the plant kingdom. Further investigations are needed to test if eNAD^+^ signaling is in play in diverse plant species and to identify eNAD^+^ receptors in these plant species.

Materials and methods {#s4}
=====================

Plant materials and growth conditions {#s4-1}
-------------------------------------

The wild type used in this study was the *Arabidopsis thaliana* (L.) Heynh. ecotype Columbia (Col-0). The T-DNA insertion lines used in this study are listed in [Supplementary file 1B](#SD6-data){ref-type="supplementary-material"}, and the *dorn1-3* mutant (SALK_042209) was previously described ([@bib22]). The T-DNA insertion lines were obtained from either Arabidopsis Biological Resource Center at The Ohio State University (Columbus, OH) or Nottingham Arabidopsis Stock Center at The University of Nottingham (Nottingham, UK). Homozygous mutant plants of the T-DNA insertion lines were confirmed with primers flanking the T-DNA insertions and the left border primers LBa1, LB3, and o8409 ([Supplementary file 1D](#SD6-data){ref-type="supplementary-material"}). The Arabidopsis seeds were sown on autoclaved soil (Sunshine MVP; Sun Gro Horticulture, Agawam, MA) and cold-treated at 4°C for 3 days. Plants were germinated and grown at 22°C to 24°C under a 16-hr-light/8-hr-dark regime. Four-week-old soil-grown plants were used for chemical treatment and pathogen infection.

Chemical and cabbage looper egg extract treatment {#s4-2}
-------------------------------------------------

NAD^+^-Na and NADP^+^-Na were dissolved in water, and the pH of the resulting solutions was adjusted to \~6.0 using 0.1 M NaOH. Flg22 was dissolved in water to make a 100 μM stock solution, which was freshly diluted before each experiment. For NAD^+^, NADP^+^, and flg22 treatment, the solution was infiltrated into *Arabidopsis* leaves using a 1 mL needleless syringe. For SA treatment, plants were soil-drenched with 0.5 mM SA, sprayed with 0.5 mM SA plus 0.1% Tween 20, and partially covered with a transparent plastic dome. Cabbage looper eggs were ordered from Benzon Research Inc. (Carlisle, PA). Generation of egg extracts and treatment with egg extracts were conducted as previously described ([@bib37]).

Pathogen infection {#s4-3}
------------------

Inoculation of *Arabidopsis* plants with the bacterial pathogen *Psm* ES4326 was performed by pressure-infiltration using a 1 mL needleless syringe. Eight leaves per genotype/treatment from eight plants were collected immediately after the inoculation and/or 3 d post-inoculation to examine the growth of the pathogen.

RNA and protein analysis {#s4-4}
------------------------

Total RNA extraction, reverse transcription, and real-time qPCR were performed as previously described ([@bib80]) using gene-specific primers ([Supplementary file 1D](#SD6-data){ref-type="supplementary-material"}). Leaf tissues for each independent RNA sample were collected from 12 plants. Protein gel blot analysis was conducted as described previously ([@bib59]).

Plasmid construction and plant transformation {#s4-5}
---------------------------------------------

For subcellular localization study, the DNA fragments encoding mGFP in pRTL2-mGFP and mCherry in pNDH-OCT were amplified using the primers XbaI-SalI-GFPF/XhoI-GFPR and XbaI-SalI-mCherryF/XhoI-mCherryR, respectively. The primers used for plasmid construction are listed in [Supplementary file 1D](#SD6-data){ref-type="supplementary-material"}. The PCR products were digested with XbaI and XhoI and cloned into XbaI/SalI-digested pCAMBIA1300S to create pCAMBIA1300S-GFP and pCAMBIA1300S-mCherry. Then the coding regions of *LecRK-I.8* and *AHA2* were amplified using the primers BamHI-flLecRK-I.8F/SalI-flLecRK-I.8R and SacI-AHA2F/SalI-AHA2R, respectively. The PCR products were digested with BamHI or SacI and SalI and cloned into the corresponding sites of pCAMBIA1300S-GFP and pCAMBIA1300S-mCherry, resulting in pCAMBIA1300S-LecRK-I.8-GFP and pCAMBIA1300S-AHA2-mCherry, respectively. For generation of transgenic *Arabidopsis* expressing eLecRK-I.8-GFP, the *LecRK-I.8* fragment encoding the extracellular domain was amplified using the primers EcoRI-ATGLecRK-I.8F and BspHI-eLecRK-I.8R. The PCR products were digested with EcoRI and BspHI and cloned into EcoRI/NcoI-digested pRTL2-mGFP to generate pRTL2-eLecRK-I.8-GFP. Then the 35S:eLecRK-I.8-GFP cassette was recovered using HindIII and subcloned into HindIII-digested and calf intestinal phosphatase-treated pCB302 to produce pCB302-35S:eLecRK-I.8-GFP. For transient expression in *N. benthamiana*, the *LecRK-I.8* fragment encoding the extracellular domain was amplified using the primers SacI-eLecRK-I.8F and SalI-HisHAeLecRK-I.8R. The PCR products were digested with SacI and SalI and cloned into the corresponding sites of the vector pCAMBIA1300S, resulting in the plasmid pCAMBIA1300S-eLecRK-I.8-HA-His. For expression of the MBP-eLecRK-I.8, MBP-eDORN1, MBP-eLecRK-I.3, MBP-eLecRK-I.6, and MBP-LecRK-I.8KD fusion proteins in *Escherichia coli*, DNA fragments encoding the corresponding domains of these proteins were amplified using the primers listed in [Supplementary file 1D](#SD6-data){ref-type="supplementary-material"}. The PCR products were digested with appropriate restriction enzymes and cloned into the corresponding sites of pMAL-p2X, generating pMAL-p2X-fragment plasmids. The plasmids pCB302-35S:eLecRK-I.8-GFP, pCAMBIA1300S-eLecRK-I.8-HA-His, pCAMBIA1300S-LecRK-I.8-GFP and pCAMBIA1300S-AHA2-mCherry were introduced into the Agrobacterium strain GV3101(pMP90) and the pMAL-p2X-fragment plasmids were introduced into the *E. coli* strain BL21(DE3) by electroporation.

*Arabidopsis* wild-type Col-0 plants were transformed with Agrobacteria carrying the pCB302-35S:eLecRK-I.8-GFP plasmid following the floral dip protocol ([@bib24]). Transient expression in *N. benthamiana* was performed as described previously with slight modifications ([@bib50]). Briefly, Agrobacteria carrying pCAMBIA1300S-LecRK-I.8-GFP, pCAMBIA1300S-AHA2-mCherry, or pCAMBIA1300S-eLecRK-I.8-HA-His were suspended in an induction buffer (10 mM MES-KOH, pH 5.6, 10 mM MgCl2 and 100 μM acetosyringone) to an OD~600~ of 0.4, preinduced for 2 to 3 hr at 28°C, and then infiltrated into *N. benthamiana* leaves using a 1 mL needleless syringe. Two to 3 d later, the leaves infiltrated with the Agrobacteria carrying pCAMBIA1300S-LecRK-I.8-GFP/pCAMBIA1300S-AHA2-mCherry and pCAMBIA1300S-eLecRK-I.8-HA-His were used for microscopy analysis and protein purification, respectively.

Protein purification {#s4-6}
--------------------

For immunoprecipitation, leaf tissues from 3-week-old soil-grown *35S:eLecRK-I.8-GFP* and *35S:GFP* plants were homogenized on ice in extraction buffer (50 mM HEPES, pH 7.5, 50 mM NaCl, 10 mM EDTA, 5 mM DTT, 1% Triton X-100, and protease inhibitors: 50 μg/mL TPCK, 50 μg/mL TLCK, and 0.6 mM PMSF). The homogenates were centrifuged at 20,000 *g* at 4°C for 20 min and the supernatants were transferred to new Eppendorf tubes. Monoclonal anti-GFP antibodies were added to the extracts (1:200). After incubation at 4°C for 1 hr, the antibody bound proteins were precipitated by adding protein G plus-agarose beads to the extracts (20 μL/mL), followed by incubation at 4°C overnight. The beads were then precipitated by centrifugation at 2000 rpm for 5 min, washed 3 times with the extraction buffer without detergent, and then used for immunoblotting and NAD^+^ binding assays. For purification of eLecRK-I.8-HA-His, agroinfiltrated *N. benthamiana* leaf tissues were homogenized on ice in extraction buffer (50 mM Tris-HCl, pH7.5, 150 mM NaCl, 0.1% Triton X-100, 0.2% Nonidet P-40, 6 mM *β*-mercaptoethanol, and protease inhibitors: 50 μg/mL TPCK, 50 μg/mL TLCK, and 0.6 mM PMSF). The homogenates were centrifuged at 20,000 g at 4°C for 20 min and the supernatants were transferred to new Eppendorf tubes. The eLecRK-I.8-HA-His protein was purified using HisPur Cobalt Resin following the manufacturer's protocol (Thermo Scientific, Waltham, MA). After washing, the resins with bound proteins were used for immunoblotting and NAD^+^ binding assays. For purification of MBP-eLecRK-I.8, MBP-eDORN1, MBP-eLecRK-I.3, MBP-eLecRK-I.6, and MBP-LecRK-I.8KD, a single colony of BL21(DE3) carrying the corresponding plasmid was cultured overnight at 37°C in 5 mL Lysogeny broth (LB) with 50 µg/mL ampicillin. One mL of the seed culture was added to 500 mL fresh LB medium with 50 µg/mL ampicillin and cultured at 37°C with shaking to an OD~600~ of 0.4. Isopropyl *β*-D-1-thiogalactopyranoside was added to a final concentration of 0.3 mM and the culture was allowed to grow for another 16--18 hr at 18°C before the cells were harvested for protein extraction. MBP-fusion proteins were purified with amylose resin according to the protocol supplied by the manufacturer (New England Biolabs, Ipswich, MA).

NAD^+^ binding assays {#s4-7}
---------------------

NAD^+^ binding experiments were performed following a previously described protocol for brassinolide binding assays ([@bib77]). Briefly, beads with the bound proteins were re-suspended in binding buffer (10 mM HEPES, pH 7.5, 5 mM MgCl~2~) and aliquoted in 86 µL portions for individual binding reactions. For total binding assay, 10 µL binding buffer and 4 µL ^32^P-labeled NAD^+^ (6.25 µM) were added, resulting in 250 nM ^32^P-labeled NAD^+^ in the final 100 µL reaction mixture. ^32^P-labeled NAD^+^ (specific activity 800 Ci/mmol) was purchased from PerkinElmer (Waltham, MA). For nonspecific binding, 10 µL of 2.5 mM unlabeled NAD^+^ and 4 µL ^32^P-labeled NAD^+^ were added, resulting in 250 µM unlabeled NAD^+^ and 250 nM ^32^P-labeled NAD^+^ in the final 100 µL reaction mixture. The mixtures were incubated for 30 min at room temperature with gentle mixing every 5 min. The beads containing the binding reactions were then precipitated by centrifugation at 2000 rpm for 5 min, washed 3 times with the binding buffer, re-suspended in 10 mL scintillation counter liquid per sample, and carefully transferred into scintillation vials. The vials were placed in a Beckman Coulter LS6500 Multi-Purpose Scintillation Counter (Beckman Coulter, Brea, CA) and bound ^32^P-labeled NAD^+^ was quantified by scintillation counting. Specific NAD^+^ binding was calculated by subtracting the nonspecific binding from the total binding. For saturation binding assay, protein G plus-agarose beads with the bound proteins were incubated with different concentrations (50, 200, 500, 1000, and 1500 nM) of ^32^P-labeled NAD^+^ in the absence (for total binding) or presence (for nonspecific binding) of additional 1000-fold unlabeled NAD^+^ in the binding buffer. For competitive binding assay, protein G plus-agarose beads with the bound proteins were incubated with 250 nM of ^32^P-labeled NAD^+^ in the presence of different concentrations (100 nM, 1 µM, 10 µM, 100 µM and 1 mM) of unlabeled nucleotides (NAD^+^, NADP^+^, ATP, ADP and AMP) in the binding buffer. The dissociation constant (*K*d) was calculated by one site specific binding saturation model using GraphPad Prism 5 ([www.graphpad.com](http://www.graphpad.com)). Inhibition constant (*K*~i~) values were calculated by importing the data points into GraphPad Prism 5 ([www.graphpad.com](http://www.graphpad.com)) using the one site Fit *K*~i~ competition model.

For microsome-based binding assays, microsomes were prepared as previously described with minor modifications ([@bib77]; [@bib18]). All steps were conducted at 4°C. Arabidopsis plants were grown under a 15-hr-light/9-hr-dark regime for about 6 weeks. Rosette leaf tissues were homogenized with a mortar and pestle in 1 mL/1 gram chilled membrane extraction buffer (20 mM Tris-HCl, pH 7.5, 250 mM mannitol, 5 mM MgCl~2~, 0.1 mM CaCl~2~, and protease inhibitors). Homogenates were filtered through two layers of Miracloth and centrifuged at 10,000 *g* for 10 min at 4°C. The supernatant was centrifuged at 100,000 *g* for 1 hr at 4°C to pellet microsomes. The microsomal pellet was resuspended at a protein concentration of 2 mg/mL in binding buffer (10 mM MES-KOH, pH 5.7, 5 mM MgCl~2~, 0.25 mM CaCl~2~, 0.25 M mannitol, and protease inhibitors). Each binding assay contains 50 μL microsomes, indicated amount (50, 200, 500, 1000 nM) of ^32^P-labeled NAD^+^, 1 mg/mL BSA, with 1000-fold excess unlabeled NAD^+^ for background binding assays. The final reaction volume was brought to 100 μL by adding binding buffer. The binding reactions were incubated for 30 min at room temperature with gentle mixing every 5 min. The bound and free ^32^P-labeled NAD^+^ were separated by filtering the mixture through a glass-fibre filter (Whatman) and washing with 10 mL ice-cold binding buffer, and were quantified by scintillation counting. Binding data were analyzed and plotted using GraphPad Prism 5.

Kinase assay {#s4-8}
------------

The kinase assay was performed as described by [@bib22] with minor modifications. Briefly, 5 µg of MBP-LecRK-I.8KD and 2 µg of myelin basic protein in a buffer (50 mM Tris-HCl pH7.5, 50 mM KCl, 10 mM MnCl~2~, 10 mM MgCl~2~) plus 1 µL of ATP (0.4 µL ^32^P-labeled ATP, 0.4 µL cold ATP, 0.2 µL H~2~O) in a total volume of 30 µL were incubated at 30°C for 30 min. ^32^P-labeled ATP (specific activity 3000 Ci/mmol) was purchased from PerkinElmer. After SDS-PAGE electrophoresis, the gel was dried and exposed to X-ray film for 3 hr.

Microarray analysis {#s4-9}
-------------------

Four-week-old soil-grown plants were treated with 1 mM NAD^+^ or water. Total RNA samples extracted from the treated leaves were subjected to microarray analysis. Briefly, RNA concentration was determined on a NanoDrop Spectrophotometer (Thermofisher Scientific, Waltham, MA) and sample quality was assessed using the 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA). cDNA was synthesized from 200 ng of total RNA and used as a template for in vitro transcription in the presence of T7 RNA Polymerase and cyanine labeled CTP's using the Quick Amp Labeling kit (Agilent Technologies) according the manufacturer's protocol. The amplified, labeled complementary RNA (cRNA) was purified using the RNeasy Mini kit (Qiagen, Valencia, CA). For each array, 1650 ng of Cy three labeled cRNA was fragmented and hybridized with rotation at 65°C for 17 hr. Samples were hybridized to Arabidopsis 4 × 44 k arrays (Agilent Technologies). The arrays were washed according to the manufacturer's protocol and then scanned on a G2505B scanner (Agilent Technologies). Data were extracted using Feature Extraction 10.1.1.1 software (Agilent Technologies).

Data (individual signal intensity values) obtained from the microarray probes were background corrected using a *normexp*+*offset* method, in which a small positive offset (*k* = 50) was added to move the corrected intensities away from zero ([@bib69]). The resulting data were log transformed (using two as the base) and normalized between individual samples using quantile normalization ([@bib73]). After normalization, a linear model was fitted on each gene for comparison using the *limma* package in R ([@bib70]). To control false discovery rate (FDR) and correct for multiple hypothesis testing, a *q* value was calculated and used to assess the significance of each test ([@bib10]). A probe-by-probe comparison was performed between different treatments using water treatment as the reference sample. In each comparison, a *q* value and fold change (FC) were computed for each gene locus. The gene expression fold changes were computed based on the normalized log-transformed signal intensity data. The comparison results were further explored to obtain numbers of overlapped genes between NAD^+^ treatment and *Pst* DC3000/*avrRpt2* infection. Pathway and gene ontology analysis were performed on deferentially expressed genes using DAVID Bioinformatics Resources ([@bib42]).

Microscopy {#s4-10}
----------

N.*N. benthamiana* leaf tissues were mounted in water and viewed with a Zeiss confocal LSM 5 Pascal microscope (Jena, Germany). GFP was visualized using an excitation wavelength of 488 nm and a bandpass 505 to 530 nm emission filter and mCherry was visualized using an excitation of 543 nm and a bandpass 600 to 680 nm emission filter.

Statistical methods {#s4-11}
-------------------

Statistical analyses were performed using the one-way ANOVA and the two-way ANOVA in Prism 5.0b (GraphPad Software, La Jolla, CA).

Accession numbers {#s4-12}
-----------------

The accession numbers of the microarrays discussed in this manuscript are GSE76568 and GSE38986 in Gene Expression Omnibus.
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###### (A) Well-known defense genes affected by NAD^+^ treatment.

\(B\) Receptor-like genes induced by NAD^+^ treatment. (C) Receptor-like kinase genes induced by *P. brassicae* oviposition and/or NAD^+^ treatment. (D) Primers used in this study.

**DOI:** [http://dx.doi.org/10.7554/eLife.25474.025](10.7554/eLife.25474.025)

Major datasets {#s7}
--------------

The following dataset was generated:

Wang C,Zhou M,Zhang X,Yao J,Zhang Y,Mou Z,2016,Microarray analysis of exogenous NAD+-induced transcriptome changes in Arabidopsis thaliana,<https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE76568>,Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE76568)

The following previously published dataset was used:

Wang Y,Zhang Y,Yao J,Sun Y,Mou Z,2012,Microarray analysis of Atelp2, npr1 and wild type (Col-0) infected with the avirulent bacterial pathogen Pst DC3000/avrRpt2,<https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE38986>,Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE38986)
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"A lectin receptor kinase senses extracellular nicotinamide adenine dinucleotide in *Arabidopsis thaliana*\" for consideration by *eLife*. Your article has been favorably evaluated by Detlef Weigel (Senior Editor) and three reviewers, one of whom is a member of our Board of Reviewing Editors. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and with the Senior Editor, and the Reviewing Editor has summarized essential revisions below.

The referees greatly appreciated the identification of Arabidopsis LecRK-I.8 as a receptor like protein that mediates bacterial immunity in plants and that is implicated in host-derived damage-associated molecular pattern recognition, clearly a timely and important topic. The genetic evidence provided in support of this conclusion is very convincing. Questions remain, however, as to whether this protein is indeed a bona fide receptor for eNAD+. Essential revisions include the following:

1\) Immunoprecipitation of epitope-tagged LecRK-I.8 is likely to pull-down numerous other proteins closely associated with the bait in membrane micro domains and/or supramolecular protein assemblies. To strengthen the suite of binding experiments you should either perform microsome-based binding assays in vivo (from WT and lecrk-I.8 mutants) or alternatively, use recombinant ectodomain protein in SPR assays (ITC, MST also appropriate) to conduct appropriate, quantitative biochemical binding assays. Such assays might also reveal the presence of the predicted second, low-affinity receptor.

2\) It is also of note that all three mutant genotypes showed substantial residual eNAD+ responses, suggesting functional redundancy of LecRK-I.8 with another, yet unknown protein. Likely, this is LecRK-I.6. Therefore, it would be important to know whether a double mutant would indeed show less or no eNAD+ responsiveness.

3\) The reported dissociation constant of the receptor with eNAD+ is approx. 450 nM, which is in stark contrast with much higher eNAD+ concentrations used to trigger plant defenses. Here, a range of much lower eNAD+ concentrations should be used in early PTI assays (ROS burst etc.) to establish clearly a link between the kD and the EC50 value for a given PTI response.

4\) Results shown in [Figure 3A](#fig3){ref-type="fig"} are insufficient to strongly demonstrate membrane-localization of LecRK-I.8.

5\) In [Figure 3B](#fig3){ref-type="fig"}, both a positive control such as DORN1 and a negative control like GFP are missing. Likewise, how often has this effect been observed and how can the authors discriminate between free GFP and epitope-tagged LecRK-I.8?

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled \"A lectin receptor kinase senses extracellular nicotinamide adenine dinucleotide in *Arabidopsis thaliana*\" for further consideration at *eLife*. Your article has been favorably evaluated by Detlef Weigel (Senior Editor) and three reviewers, one of whom is a member of our Board of Reviewing Editors.

The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance.

All referees acknowledge the improvements during the revision, but they continue to have concerns regarding ligand binding of LecRK-I.8 that you should address before final approval. We do not expect you to conduct additional experiments here, but you should include clear statements that:

i\) there are differences in ligand affinities between OE and wild-type plants, andii) the significant differences between Kd values and the concentrations used to trigger defenses are rather unusual and difficult to reconcile with a primary ligand sensor function of LecRK-I.8.

Our sense is that while LecRK-I.8 is surely implicated in eNAD+ perception, your data suggest rather than show that this protein is indeed the bona fide ligand binding site. With such an explanatory statement added we will be happy to accept your manuscript. This should be reflected in title and Abstract. E.g.

\"A lectin receptor kinase *as a potential sensor* for extracellular nicotinamide adenine dinucleotide...\"

and

\"Here, we identify a lectin receptor kinase (LecRK), LecRK-I.8, as a *potential* eNAD+ receptor in Arabidopsis. The extracellular lectin domain of LecRK-I.8 *deleted* binds NAD+ with a dissociation constant of 436.5 ± 104.8 nM, *although much higher concentrations are needed to trigger* in vivo *responses*. Transferred DNA insertion knockout of LecRK-I.8 particularly inhibits NAD+-induced immune responses, whereas overexpression of LecRK-I.8 enhances the Arabidopsis response to NAD+. Furthermore, we show that LecRK-I.8 is required for Arabidopsis basal resistance against bacterial pathogens, substantiating a role for eNAD+ in plant immunity. Our results demonstrate that cell-surface lectin receptors can \*potentially\* function as eNAD+-binding receptors and provide direct evidence for eNAD+ being a bona fide endogenous signaling molecule in plants.\"

10.7554/eLife.25474.031

Author response

*The referees greatly appreciated the identification of Arabidopsis LecRK-I.8 as a receptor like protein that mediates bacterial immunity in plants and that is implicated in host-derived damage-associated molecular pattern recognition, clearly a timely and important topic. The genetic evidence provided in support of this conclusion is very convincing. Questions remain, however, as to whether this protein is indeed a bona fide receptor for eNAD+. Essential revisions include the following:*

*1) Immunoprecipitation of epitope-tagged LecRK-I.8 is likely to pull-down numerous other proteins closely associated with the bait in membrane micro domains and/or supramolecular protein assemblies. To strengthen the suite of binding experiments you should either perform microsome-based binding assays* in vivo *(from WT and lecrk-I.8 mutants) or alternatively, use recombinant ectodomain protein in SPR assays (ITC, MST also appropriate) to conduct appropriate, quantitative biochemical binding assays. Such assays might also reveal the presence of the predicted second, low-affinity receptor.*

As suggested, we performed microsome-based binding assays using wild-type, lecrk-I.8-2, and 35S:LecRK-I.8 plants. We observed a dramatic increase of NAD^+^ binding activity in the membrane fractions of the *35S:LecRK-I.8* transgenic plants and a clear decrease of NAD^+^ binding activity in the membrane fractions of the *lecrk-I.8-2* mutant plants. Furthermore, the lecrk-I.8-2 mutant membrane fractions still showed certain levels of NAD+ binding activity, indicating that there are other NAD+ receptors in Arabidopsis. These results are presented in [Figure 5D](#fig5){ref-type="fig"} and in the text.

*2) It is also of note that all three mutant genotypes showed substantial residual eNAD+ responses, suggesting functional redundancy of LecRK-I.8 with another, yet unknown protein. Likely, this is LecRK-I.6. Therefore, it would be important to know whether a double mutant would indeed show less or no eNAD+ responsiveness.*

We thank the editor and the reviewers for this suggestion. We cloned the cDNA fragment encoding the extracellular domain of LecRK-I.6 into pMAL-p2x and purified the MBP-eLecRK-I.6 fusion protein. NAD+ binding assays revealed that while simultaneously purified MBP-eLecRK-I.8 bound NAD+, MBP and MBP-eLecRK-I.6 did not ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}), indicating that LecRK-I.6 is not an eNAD+-binding receptor. This result has been added in the text. Although we have transformed a CRISPR/Cas9 construct into lecrk-I.8-2 to create a double mutant, it is not necessary to wait for the double mutant based on the NAD+ binding assay result.

*3) The reported dissociation constant of the receptor with eNAD+ is approx. 450 nM, which is in stark contrast with much higher eNAD+ concentrations used to trigger plant defenses. Here, a range of much lower eNAD+ concentrations should be used in early PTI assays (ROS burst etc.) to establish clearly a link between the kD and the EC50 value for a given PTI response.*

As suggested, we used a series of low concentrations (0, 0.5, 5, and 50 μM) of NAD+ to treat the plants and analyzed the induction of several early PAMP-responsive genes including GST1, FRK1, NHO1, and WRKY29. As shown in [Figure 5---figure supplement 3](#fig5s3){ref-type="fig"}, 5 μM NAD+ significantly induced GST1 and FRK1 expression. This result has been added in the text. Moreover, it seems that 0.5 μM of NAD+ is able to induce FRK1, although the induction was not statistically significant.

*4) Results shown in [Figure 3A](#fig3){ref-type="fig"} are insufficient to strongly demonstrate membrane-localization of LecRK-I.8.*

To further demonstrate that LecRK-I.8 is localized at the plasma membrane, we co-transformed LecRK-I.8-GFP and AHA2-mCherry into *N. benthamiana* and found that the GFP and mCherry signals precisely overlapped with each other. Since AHA2 is a well-established plasma membrane localized P-type H^+^-ATPase, this result indicates that LecRK-I.8 is localized at the plasma membrane. The result is presented in [Figure 3B](#fig3){ref-type="fig"} and in the text.

*5) In [Figure 3B](#fig3){ref-type="fig"}, both a positive control such as DORN1 and a negative control like GFP are missing. Likewise, how often has this effect been observed and how can the authors discriminate between free GFP and epitope-tagged LecRK-I.8?*

We thank the editor and the reviewers for this point. We used DORN1-GFP as the positive control and GFP as the negative control. To our surprise, expression of GFP alone also appeared to affect plasmolysis to some extent. We repeated the experiment many times and tested different time points. Unfortunately, we do not feel confident to conclude that expression of GFP alone does not affect plasmolysis. For this reason, we removed the plasmolysis results in the revised manuscript.

We think that the results from the co-localization experiment and the microsomal binding assays are sufficient to demonstrate the plasma membrane localization of LecRK-I.8.

GFP and LecRK-I.8-GFP can be easily distinguished by their subcellular localization. While GFP is localized in the cytoplasm and nucleus, LecRK-I.8-GFP is in the plasma membrane ([Figure 3B](#fig3){ref-type="fig"}).

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

*The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance.*

*All referees acknowledge the improvements during the revision, but they continue to have concerns regarding ligand binding of LecRK-I.8 that you should address before final approval. We do not expect you to conduct additional experiments here, but you should include clear statements that:*

*i) there are differences in ligand affinities between OE and wild-type plants, andii) the significant differences between Kd values and the concentrations used to trigger defenses are rather unusual and difficult to reconcile with a primary ligand sensor function of LecRK-I.8.*

*Our sense is that while LecRK-I.8 is surely implicated in eNAD+ perception, your data suggest rather than show that this protein is indeed the bona fide ligand binding site. With such an explanatory statement added we will be happy to accept your manuscript. This should be reflected in title and Abstract. E.g.*

*\"A lectin receptor kinase as a potential sensor for extracellular nicotinamide adenine dinucleotide...\"*

*and*

*\"Here, we identify a lectin receptor kinase (LecRK), LecRK-I.8, as a potential eNAD+ receptor in Arabidopsis. The extracellular lectin domain of LecRK-I.8 deleted binds NAD+ with a dissociation constant of 436.5 ± 104.8 nM, although much higher concentrations are needed to trigger* in vivo *responses. Transferred DNA insertion knockout of LecRK-I.8 particularly inhibits NAD+-induced immune responses, whereas overexpression of LecRK-I.8 enhances the Arabidopsis response to NAD+. Furthermore, we show that LecRK-I.8 is required for Arabidopsis basal resistance against bacterial pathogens, substantiating a role for eNAD+ in plant immunity. Our results demonstrate that cell-surface lectin receptors can \*potentially\* function as eNAD+-binding receptors and provide direct evidence for eNAD+ being a bona fide endogenous signaling molecule in plants.\"*

Based on your suggestions, we have made the following changes in the revised manuscript.

1\) As suggested, the title has been changed to "A lectin receptor kinase as a potential sensor for extracellular nicotinamide adenine dinucleotide in *Arabidopsis thaliana*".

2\) Changes have also been made in the Abstract as suggested: "potential" was added; "although much higher concentration are needed to trigger in vivo responses" was added; and "specifically" was deleted. Additionally, the Abstract was shortened to 150 words.

3\) In the last paragraph of the Introduction, "potential" and "potentially" was added.

4\) In the subsection "LecRK-I.8 specifically binds NAD^+^", first paragraph: "Interestingly, there were differences in ligand affinities between the membrane fractions of the *35S:LecRK-I.8* plants and the wild type, which might suggest possible conformation changes when LecRK-I.8 is overexpressed in plants." was added; "in line with this result" was replaced by "on the other hand"; "indicating that the NAD^+^ concentrations required to trigger defense responses are significantly higher than the *K*~d~ value of LecRK-I.8, which is rather unusual and difficult to reconcile with a primary ligand sensor function of LecRK-I.8." was added.

5\) In the last paragraph of the subsection "*LecRK-I.8* specifically binds NAD^+^": "demonstrates" was replaced with "suggests" and "is" was replaced with "may be". At the end of the subsection "Mutations in *LecRK-I.8* particularly inhibit NAD^+^-induced defense responses", "support the conclusion" and "specific" were replaced with "suggest" and potential", respectively.

6\) In the first and second paragraphs of the Discussion, "potential" was added; "bona fide" was replaced with "potential"; and "demonstrates" was replaced with "suggest".

7\) In the third paragraph of the Discussion, "potential" was added.

8\) In the fourth paragraph of the Discussion, "potentially" was added.

[^1]: These authors contributed equally to this work.
